patent semaglutide The for the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in India on March 20, opening the door for a wave of low-cost Off-patent semaglutide in 2026: the
Pay in 4 interest-free payments of $5.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16






















